Factors associated with hepatitis C prevalence differ by the stage of liver fibrosis: A cross-sectional study in the general pop
May 2014 by McMahon Group - Issuu
Interpretarea analizelor in hepatita C
HBs Ag, anti-HCV, anti-HIV EIA screening test results and repeating... | Download Table
The Swiss STAR trial – an evaluation of target groups for sexually transmitted infection screening in the sub-sample of women
PDF) Mapping Rare Erythrocyte Phenotypes in Morocco: A Tool to Overcome Transfusion Challenges | Abdelmajid SOULAYMANI - Academia.edu
PDF) KASL clinical practice guidelines: Management of hepatitis C
Journal of Infection
S/CO ratio of anti-HCV antibody, plasma HCV viral load and... | Download Scientific Diagram
HCV Diagnosis and Sequencing Using Dried Blood Spots from Patients in Kinshasa (DRC): A Tool to Achieve WHO 2030 Targets
Anticorpi anti-HCV
Elecsys® Anti-HCV II
IMPACT FACTOR
A comparative review of immunoassays for COVID-19 detection
LMI 6-7-13_STI-March-Quark4
HCV Diagnosis and Sequencing Using Dried Blood Spots from Patients in Kinshasa (DRC): A Tool to Achieve WHO 2030 Targets
XXIII Annual Meeting of the Latin American Association for the Study of the Liver and the National Congress of the Mexican Assoc
HBs Ag, anti-HCV, anti-HIV EIA screening test results and repeating... | Download Table
PDF) Detection of Infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots - performance characteristics of the ARCHITECT system and two commercial assays
Systematic review of the accuracy of antibody tests used to screen asymptomatic adults for hepatitis C infection
A study based on four immunoassays: Hepatitis C virus antibody against different antigens may have unequal contributions to detection | Virology Journal | Full Text
Frequency of HBsAg, anti-HCV, and anti-HIV1/2 repeatedly reactive or... | Download Table
HCV Diagnosis and Sequencing Using Dried Blood Spots from Patients in Kinshasa (DRC): A Tool to Achieve WHO 2030 Targets
Untitled
Anticorpi anti HCV (hepatita C) | MedLife
